Positron Corporation announced the consolidation and integration of operations at the Crown Point, Indiana facility to its Lubbock, Texas site. With the acquisition of Manhattan Isotope Technology (MIT), the company gained the expertise, knowledge and radioactive materials facilities to manage all of the Company's radiopharmaceutical and radioisotope development, production, processing and distribution mission. By locating all radioactive production to a single facility, Positron will simplify and improve regulatory compliance, radiation safety and quality procedures associated with the production of radioisotopes and radiopharmaceuticals.

Additionally, this consolidation will significantly improve efficiencies, economics, and utilization throughout the company.